ZHENJIANG CITY, JIANGSU PROVINCE, CHINA, March 3, 2026 /EINPresswire.com/ -- The global coaxial cable market has been ...

JIAXING CITY, ZHEJIANG PROVINCE, CHINA, March 2, 2026 /EINPresswire.com/ -- The global market for PVC panels has ...

NEW YORK, Feb 19 (Reuters) - Online telehealth company Hims & Hers Health, seeking growth drivers as its original sexual-health franchises matured, may have overstepped with a risky launch of ...

An exclusive accreditation program for APC members—priced at up to half the cost of other accreditations. One accreditation. Real compliance. Less frustration ...

Shares of financial technology company SoFi Technologies have lagged behind the broader market this year. Some analysts are urging Wall Street to look past this underperformance.

I own T. Rowe Price Capital Appreciation Equity TCAF because David Giroux is one of the best flexible-equity investors out there. He’s moved around the style box in search of the most compelling ...

After crackdown threats from the FDA, Hims & Hers quickly pulled its copycat Wegovy pill, a cheaper compounded form of semaglutide. Compounded drugs are not FDA-approved and don’t go through the same ...

Hims lawsuit is Novo's first US patent case over Wegovy compounding Novo previously sued small compounders for false advertising, trademark issues Patent lawsuits are more complex but could lead to ...

COPENHAGEN, Denmark — Novo Nordisk sued Hims and Hers Health on Monday over alleged patent infringement after the U.S. telehealth firm launched, then canceled, a $49 copy of Novo's weight-loss pill ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Ed Silverman, a senior ...

Hims & Hers (HIMS) shares dropped 16% after-hours as FDA plans to restrict compounded GLP-1 ingredients and HHS referred Hims to DOJ. Hims projected $725M in weight-loss revenue for 2025 from total ...